Features of iPSCs as starting materials that can transform cell therapies into standard care

How can using iPSCs as starting materials help with transforming cell therapies into standard care? This infographic highlights the key features of iPSCs as starting materials, from donor consent through to commercial innovation.

This infographic was created by RegMedNet in association with RheinCell Therapeutics.

This infographic is part of the RegMedNet In Focus on cellular starting materials for cell therapies. Discover expert opinions on this, including features of iPSCs as starting materials, now.

Visit the feature

RMN-Rheincell-In-focus-infographic-1-1-2